mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |